Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner

Cardiovascular Research

Volumn 90, Issue 1, 2011, Pages 140-147

  Schreiner, Cornelia E ^a   Kumerz, Mario ^a   Gesslbauer, Julia ^a   Schachner, Daniel ^a   Joa, Helge ^a   Erker, Thomas ^a   Atanasov, Atanas G ^a   Heiss, Elke H ^a   Dirsch, Verena M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiotensin II; Epidermal growth factor; Redox regulation; Vascular smooth muscle cells

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN II; DICHLORODIHYDROFLUORESCEIN DIACETATE; DIPHENYLIODONIUM SALT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN GP 91; HYDROGEN PEROXIDE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; RESVERATROL; SMALL INTERFERING RNA;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; DOWN REGULATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; CELL SHAPE; CELLS, CULTURED; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; HYDROGEN PEROXIDE; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STILBENES; TIME FACTORS; TRANSFECTION;

EID: 79952831059     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq355     Document Type: Article

References (34)

1. Schmitt CA, Dirsch VM. Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide 2009;21:77-91.
2. Opie LH, Lecour S. The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J 2007;28:1683-1693. (Pubitemid 47227092)
3. Leifert WR, Abeywardena MY. Cardioprotective actions of grape polyphenols. Nutr Res 2008;28:729-737.
4. Haider UG, Sorescu D, Griendling KK, Vollmar AM, Dirsch VM. Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol 2002;62:772-777.
5. Haider UG, Roos TU, Kontaridis MI, Neel BG, Sorescu D, Griendling KK et al. Resveratrol inhibits angiotensin II-and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2. Mol Pharmacol 2005;68:41-48. (Pubitemid 41002943)
6. Heeneman S, Sluimer JC, Daemen MJAP. Angiotensin-converting enzyme and vascular remodeling. Circ Res 2007;101:441-454. (Pubitemid 47347875)
7. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292: C82-C97. (Pubitemid 46127306)
8. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, AlexanderRW. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001;21:489-495. (Pubitemid 32323378)
9. Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 2007;112:417-428. (Pubitemid 46587457)
10. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006;71: 247-258.
11. Chen K, Thomas SR, Keaney JF Jr. Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic Biol Med 2003;35:117-132. (Pubitemid 36835912)
12. Bedard K, Krause K-H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245-313. (Pubitemid 46209993)
13. Cave A. Selective targeting of NADPH oxidase for cardiovascular protection. Curr Opin Pharmacol 2009;9:208-213.
14. Sumimoto H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J 2008;275:3249-3277. (Pubitemid 351813551)
15. Brandes RP, Schroder K. Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases. Trends Cardiovasc Med 2008;18:15-19.
16. Brown DI, Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 2009;47:1239-1253.
17. Ushio-Fukai M, Zuo L, Ikeda S, Tojo T, Patrushev NA, Alexander RW. cAbl tyrosine kinase mediates reactive oxygen species-and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy. Circ Res 2005;97: 829-836. (Pubitemid 41447134)
18. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004;24:677-683. (Pubitemid 38451603)
19. DeYulia GJ Jr, Carcamo JM, Borquez-Ojeda O, Shelton CC, Golde DW. Hydrogen peroxide generated extracellularly by receptor-ligand interaction facilitates cell signaling. Proc Natl Acad Sci USA 2005;102:5044-5049.
20. Halvey PJ, Watson WH, Hansen JM, Go Y-M, Samali A, Jones DP. Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling. Biochem J 2005;386:215-219. (Pubitemid 40343778)
21. DeYulia GJ Jr, Cárcamo JM. EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases. Biochem Biophys Res Commun 2005;334:38-42. (Pubitemid 40978504)
22. Lassègue B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y et al. Novel gp91phox homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001;88: 888-894. (Pubitemid 32441466)
23. Griendling KK, Taubman MB, Akers M, Mendlowitz M, Alexander RW. Characterization of phosphatidylinositol-specific phospholipase C from cultured vascular smooth muscle cells. J Biol Chem 1991;266:15498-15504. (Pubitemid 21907676)
24. Huang X-F, Ruan B-F, Wang X-T, Xu C, Ge H-M, Zhu H-L et al. Synthesis and cytotoxic evaluation of a series of resveratrol derivatives modified in C2 position. Eur J Med Chem 2007;42:263-267. (Pubitemid 46282222)
25. Majander A, Finel M, Wikström M. Diphenyleneiodonium inhibits reduction of ironsulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (Complex I). J Biol Chem 1994;269:21037-21042. (Pubitemid 24266472)
26. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G et al. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 2001;276:22586-22594.
27. Oueiroz AN, Gomes BAQ, Moraes WM Jr, Borges RS. A theoretical antioxidant pharmacophore for resveratrol. Eur J Med Chem 2009;44:1644-1649.
28. Cheng TH, Liu JC, Lin H, Shih NL, Chen YL, Huang MT et al. Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy. Naunyn-Schmiedebergs Arch Pharmacol 2004;369:239-244. (Pubitemid 38270782)
29. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptormediated tyrosine phosphorylation. J Biol Chem 1997;272:217-221. (Pubitemid 27021147)
30. Chen K, Kirber MT, Xiao H, Yang Y, Keaney JF Jr. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 2008;181:1129-1139. (Pubitemid 351915488)
31. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidasederived ROS. Antioxid Redox Signal 2009;11:1289-1299.
32. Zhang H, Zhang J, Ungvai Z, Zhang C. Resveratrol improves endothelial function: role of TNFa and vascular oxidative stress. Arterioscler Thromb Vasc Biol 2009;29: 1164-1171.
33. Chow SE, Hshu YC, Wang JS, Chen JK. Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages. J Appl Physiol 2007;102:1520-1527.
34. Orallo F, Alvarez E, Camina M, Leiro JM, Gomez E, Fernandez P. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 2002;61:294-302. (Pubitemid 34112803)